SCHEMBL8734213

SCHEMBL8734213

CC(C)(C)OC(=O)NC(Cc1ccc(OCc2ccccc2)cc1)C(O)C(F)(F)C(=O)N1CCOCC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
YAP1 P46937 3/20 0.47
BCL2 P10415 1/20 0.46
PTPN1 P18031 1/20 0.44
CTSS P25774 2/20 0.44
REN P00797 1/20 0.44
TACR2 P21452 2/20 0.43
ACE P12821 1/20 0.42
KLK5 Q9Y337 1/20 0.42
HRH2 P25021 1/20 0.42
HRH1 P35367 1/20 0.42
ALDH1A1 P00352 3/20 0.42
KMT2A Q03164 2/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 2/20 0.42
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7331235 0.86 BCL2 (0.55) YAP1BCL2PTPN1CTSSREN
SCHEMBL8735984 0.84 CTSD (0.49) CTSSTACR2
SCHEMBL9090237 0.82 HRH2 (0.57) YAP1BCL2PTPN1ACEHRH2
SCHEMBL27426829 0.82 HRH2 (0.57) YAP1BCL2PTPN1ACEHRH2
SCHEMBL8736231 0.82 BCL2 (0.49) YAP1BCL2PTPN1RENKLK5
SCHEMBL8734654 0.82 LTA4H (0.52) CTSSRENTACR2ALDH1A1KMT2A
SCHEMBL7422374 0.81 BCL2 (0.49) BCL2PTPN1RENKLK5
SCHEMBL8945503 0.79 REN (0.49) YAP1BCL2PTPN1RENKLK5
SCHEMBL8093075 0.79 PPARA (0.48) YAP1BCL2PTPN1CTSSREN
SCHEMBL7425378 0.79 GAA (0.53) YAP1BCL2PTPN1TACR2ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5716973-A ADMINISTERING DIFLUORO STATONE ANALOGS MERRELL PHARMACEUTICALS INC. (US) 1998-02-10 US disclosed
US-5559140-A VIRICIDES MERRELL PHARMACEUTICALS INC. (US) 1996-09-24 US disclosed
EP-0565631-B1 ANTI-VIRAL COMPOUNDS MERRELL PHARMA INC (US) 1996-09-18 EP disclosed
EP-0565631-A1 ANTI-VIRAL COMPOUNDS. MERRELL DOW PHARMA (US) 1993-10-20 EP disclosed
WO-1992012123-A1 ANTI-VIRAL COMPOUNDS MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-23 WO disclosed